Journal der Deutschen Dermatologischen Gesellschaft

Papers
(The H4-Index of Journal der Deutschen Dermatologischen Gesellschaft is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
976369978
Schwere atopische Dermatitis im frühen Kindesalter: Besonderheiten, Herausforderungen und neue Perspektiven in der Versorgung859190323
Severe atopic dermatitis in early infancy: characteristics, challenges and new perspectives in clinical practice842280240
Kongresskalender 2024842021426
S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma – short version, part 1: diagnosis, interventions for actinic keratoses, care structures and quality‐of‐care indicators39
S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma (cSCC) – short version, part 2: epidemiology, surgical and systemic treatment of cSCC, follow‐up, prevention and occupational d38
COVID‐19 and immunological regulations – from basic and translational aspects to clinical implications29
JAK‐inhibitors in dermatology – small molecules, big impact? Overview of the mechanism of action, previous study results and potential adverse effects27
Drug‐induced photosensitivity: culprit drugs, potential mechanisms and clinical consequences26
Update “Systemic treatment of atopic dermatitis” of the S2k‐guideline on atopic dermatitis26
Lichen planus – a clinical guide25
COVID‐19 and implications for dermatological and allergological diseases25
German S3‐Guideline on the treatment of Psoriasis vulgaris, adapted from EuroGuiDerm – Part 1: Treatment goals and treatment recommendations22
Stigmatization caused by hair loss – a systematic literature review20
Overdiagnosis of melanoma – causes, consequences and solutions20
Modern therapies in atopic dermatitis: biologics and small molecule drugs20
Inpatient care for skin diseases in Germany: multi‐source analysis on the current and future health care needs19
German S3‐Guideline on the treatment of Psoriasis vulgaris, adapted from EuroGuiDerm – Part 2: Treatment monitoring and specific clinical or comorbid situations19
Non‐alcoholic fatty liver disease and psoriasis – is there a shared proinflammatory network?18
0.074791193008423